{"disease":{"id":"episodic-migraine","name":"episodic migraine"},"drugs":{"marketed":[{"drug_id":"atogepant","indication_name":"Preventive treatment of episodic migraine in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qulipta","generic_name":"ATOGEPANT","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide type 1 receptor","drug_class":"Calcitonin Gene-related Peptide Receptor Antagonist [EPC]","quality_score":66,"revenue":"201","mechanism":"Qulipta works by blocking the action of a natural chemical called calcitonin gene-related peptide type 1, which is involved in migraine pain."},{"drug_id":"fremanezumab-vfrm","indication_name":"Preventive treatment of episodic migraine in pediatric patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fremanezumab-Vfrm","company_name":"Manhattan Beach Orthodontics","drug_phase":"marketed","molecular_target":"calcitonin gene-related peptide (CGRP)","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Fremanezumab-vfrm binds to CGRP and blocks its interaction with the receptor."}],"pipeline":[{"drug_id":"rimegepant-75-mg","indication_name":"Preventive treatment of episodic migraine","indication_type":"pipeline","phase":"Phase 4","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75 MG","generic_name":"rimegepant-75-mg","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"Calcitonin gene-related peptide (CGRP) receptor","drug_class":"CGRP receptor antagonist (gepant)","quality_score":25,"revenue":null,"mechanism":"Rimegepant selectively antagonizes the calcitonin gene-related peptide (CGRP) receptor to block migraine pain signaling."}],"offLabel":[],"totalMarketed":2,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT07103694","title":"i-NEED: NEw migrainE Drugs Database","phase":"","overall_status":"RECRUITING","enrollment_count":2641,"lead_sponsor_name":"IRCCS San Raffaele Roma","has_results":false},{"nct_id":"NCT05281770","title":"Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Austrian Migraine Registry Collaboration","has_results":false},{"nct_id":"NCT03777059","title":"12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":910,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03333109","title":"Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05028569","title":"Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":775,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06047457","title":"A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":751,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT03700320","title":"Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":744,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03939312","title":"Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":685,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT06625060","title":"A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":641,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT03927144","title":"Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":621,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04686136","title":"A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":596,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT05127486","title":"A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT05853900","title":"Study of Two Digital Therapeutics for the Prevention of Episodic Migraine","phase":"NA","overall_status":"COMPLETED","enrollment_count":568,"lead_sponsor_name":"Click Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03963232","title":"A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":520,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT06248671","title":"Prophylactic Treatment With Atorvastatin for Episodic Migraine.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"St. Olavs Hospital","has_results":false},{"nct_id":"NCT05207865","title":"Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":441,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03238781","title":"Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04740827","title":"Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05897320","title":"A Study of Eptinezumab in Pediatric Participants With Episodic Migraine","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":315,"lead_sponsor_name":"H. Lundbeck A/S","has_results":false},{"nct_id":"NCT02025556","title":"A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D, Inc.","has_results":true},{"nct_id":"NCT02569853","title":"DFN-11 Injection in Episodic Migraine With or Without Aura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":268,"lead_sponsor_name":"Dr. Reddy's Laboratories Limited","has_results":true},{"nct_id":"NCT05264129","title":"Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":263,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03096834","title":"A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06692088","title":"\"Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment\"","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":216,"lead_sponsor_name":"Fundación Marques de Valdecilla","has_results":false},{"nct_id":"NCT04437433","title":"A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06051604","title":"Mi-Helper Transnasal Cooling for Acute Treatment of Migraine","phase":"NA","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"CoolTech LLC","has_results":false},{"nct_id":"NCT05449145","title":"The Effects of Vitamin D Plus Omega-3 Polyunsaturated Fatty Acids in Patients With Episodic Migraine","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Kuang Tien General Hospital","has_results":false},{"nct_id":"NCT06450444","title":"The RECLAIM Study.","phase":"NA","overall_status":"RECRUITING","enrollment_count":110,"lead_sponsor_name":"Salvia BioElectronics","has_results":false},{"nct_id":"NCT06004388","title":"Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Click Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05042037","title":"Probiotics as Adjunctive Migraine Prophylaxis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":64,"lead_sponsor_name":"Universiti Putra Malaysia","has_results":false},{"nct_id":"NCT03526874","title":"Occipital Blocks for Acute Migraine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":true},{"nct_id":"NCT07221292","title":"Pivotal Study of N-acetyl-L-leucine for CACNA1A","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"IntraBio Inc","has_results":false},{"nct_id":"NCT06229834","title":"Chiropractic Care for Episodic Migraine","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04828941","title":"My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Unidade Local de Saúde de Matosinhos, EPE","has_results":false},{"nct_id":"NCT06997562","title":"Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"New Valley University","has_results":false},{"nct_id":"NCT05210192","title":"Sphenopalatine Ganglion Blockade in Migraine","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Afyonkarahisar Health Sciences University","has_results":false},{"nct_id":"NCT05742191","title":"The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT03132233","title":"Energy for the Brain","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT07496034","title":"Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Tsai, Chueh-Yi, MD","has_results":false},{"nct_id":"NCT06751732","title":"Craniocervical Flexion Training for Reducing Migraine Headaches and Disability","phase":"NA","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Riphah International University","has_results":false},{"nct_id":"NCT04031781","title":"The Role of Left Prefrontal Transcranial Magnetic Stimulation in Episodic Migraine Prophylaxis","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT04936061","title":"Transnasal Cooling for Migraine","phase":"NA","overall_status":"TERMINATED","enrollment_count":24,"lead_sponsor_name":"CoolTech LLC","has_results":true},{"nct_id":"NCT05454319","title":"Cerebri Biofeedback Feasibility Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Nordic Brain Tech AS","has_results":false},{"nct_id":"NCT04166045","title":"Evaluation of Peripheral Nerve Stimulation for Acute Treatment of Migraine Pain","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Theranova, L.L.C.","has_results":false}],"total":44},"guidelines":[],"source":"Drug Landscape verified database"}